Cantor Fitzgerald, L. P. Neuro Sense Therapeutics Ltd. Transaction History
Cantor Fitzgerald, L. P.
- $2.48 Billion
- Q4 2024
Shares
1 transactions
Others Institutions Holding NRSN
# of Institutions
14Shares Held
647KCall Options Held
0Put Options Held
0-
Ken Griffin Citadel Advisors LLC | Chicago, Il254KShares$276,8560.0% of portfolio
-
Morgan Stanley New York, NY103KShares$111,8130.0% of portfolio
-
Jane Street Group, LLC New York, NY64.6KShares$70,4530.0% of portfolio
-
Hrt Financial LP New York, NY64.4KShares$70,1850.0% of portfolio
-
Xtx Topco LTD London, X041.9KShares$45,6670.0% of portfolio
About NeuroSense Therapeutics Ltd.
- Ticker NRSN
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,674,000
- Market Cap $12.7M